The World’s Largest Gathering of IPF Drug Developers

The IPF Summit focuses exclusively on closing the translational gap between preclinical predictability and clinical attrition to accelerate the development of truly curative idiopathic pulmonary fibrosis (IPF) therapeutics.

With the 2019 conference expanding upon an even greater breadth and depth of content, you’ll hear three days of unrivalled scientifically driven and case-study based analysis and discussion, as together leading academia and biopharma advance the IPF drug development frontier.

Last year, over 90 of IPF’s expert drug developers came together to advance the standardisation of imaging, share clinical insights, and evaluate better recapitulating disease physiology in vitro exclusively for IPF.

“This was a superb meeting combining several emerging themes in IPF therapies and a dynamic mix of formal presentations with impromptu networking. All the speakers were excellent, and every session provided novel and important insight regarding IPF. The effort the speakers put into their presentations was evident. Great job!”

Ceders-Sinai Medical Center

Want to be part of the IPF Summit 2020? Let us know and you'll be the first to receive the agenda!

“This was the best pragmatic development conference for pulmonary fibrosis that I have been too.” 

- Biogen

“I thought this disease specific conference was informative, by planning a concentrated topic it gave an opportunity to look through a tighter lens."

- Genentech

“Very well organized and informative, bringing together some very experienced professionals in the IPF world.”

- Mayo Clinic